Early fluid removal for infected belly fluid
Part of Digestive system, Infections clinical trials.
This trial tests whether removing infected fluid from the belly early helps people with cirrhosis and an infection called SBP. It may reduce the chance of complications and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have cirrhosis of the liver.
- You have an infection in the fluid around your belly called SBP.
- You have a French social security number.
- You are not pregnant, not in prison, and not under legal guardianship.
- You have not had surgery in the belly in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with cirrhosis who have had a first infection in the belly fluid (called SBP). The goal is to find out how often this infection returns and what factors might predict it coming back.
This study looks at ways to predict a serious infection in the belly fluid (called spontaneous bacterial peritonitis) that can happen in people with cirrhosis. It aims to find easy markers to catch this infection early and help guide treatment.
This study tests a new way to detect bacteria in the fluid in your belly (ascites) to see if it can quickly diagnose a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis. If you have cirrhosis and ascites, this trial may help improve how fast infections are found.
This study looks at whether simple blood tests (platelet count, sodium level, and a new index called ALBI) can help predict a serious infection in the belly fluid (spontaneous bacterial peritonitis) in people with cirrhosis and ascites.
This study tests a new scoring system to predict if patients with liver cirrhosis and ascites (fluid in the belly) will develop a serious infection called spontaneous bacterial peritonitis. It aims to help doctors identify high-risk patients earlier so they can be monitored more closely.
This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.